Evaluation of the CRISPR/Cas9 system as genome editing platform for the Mucopolysaccharidosis IV A using a strategy for induction of higher homologous recombination frequency. Universitas Scientiarum, [S. l.], v. 30, p. 82–106, 2025. DOI: 10.11144/. Disponível em: https://revistas.javeriana.edu.co/index.php/scientarium/article/view/39188. Acesso em: 13 may. 2025.